scholarly journals Conduct Disorder-Related Hospitalization and Substance Use Disorders in American Teens

2019 ◽  
Vol 9 (7) ◽  
pp. 73
Author(s):  
Anum Masroor ◽  
Rikinkumar S. Patel ◽  
Narmada N. Bhimanadham ◽  
Sanjeetha Raveendran ◽  
Naveed Ahmad ◽  
...  
Keyword(s):  
Substance Use ◽  
Alcohol Use ◽  
Conduct Disorder ◽  
Substance Use Disorders ◽  
Nationwide Inpatient Sample ◽  
Cannabis Use ◽  
Psychiatric Illnesses ◽  
Related Quality ◽  
Health Related

Objective: Our study aimed to compare the demographic characteristics of conduct disorder (CD) inpatients versus other psychiatric inpatients in children and adolescents, and assess the association between conduct disorder patients and the spectrum of substance use disorders (SUD). Methods: We included 800,614 psychiatric adolescent (12–18 years) inpatients, and this included 8885 inpatients (1.1%) primarily for conduct disorder in the Nationwide Inpatient Sample (2010–2014). ICD-9 codes were used to detect SUD, and a logistic regression model was used to evaluate the odds ratio (OR) for SUD in conduct disorder inpatients. Results: A higher proportion of conduct disorder inpatients were of 12–15 years of age (62.6%), male (64.4%), and White (45.7%). The lower median household income was correlated with a higher prevalence of conduct disorder (36.4%). Among SUD, cannabis use (23.7%) was most prevalent in conduct disorder inpatients followed by tobacco and alcohol use (10.1% each). Conduct disorder inpatients have 1.7-fold higher odds (95% confidence interval (CI) 1.52–1.82) for alcohol use and 1.4-fold higher odds (95% CI 1.31–1.49) for cannabis use compared to the non-conduct disorder inpatients. Cannabis use was seen significantly in adolescents (49.1%, 12–15 years), male (75.6%), and African Americans (45.6%). Conclusion: Conduct disorder inpatients have a higher risk of comorbid SUD compared to other psychiatric illnesses. The most common substance to be abused is cannabis followed by tobacco and alcohol. Varying pattern of substance use was seen by demographics and these predictors may help the clinicians for early diagnosis and treatment to improve overall health-related quality of life.

Sleep disturbances are associated with reduced health-related quality of life in patients with substance use disorders

2015 ◽  
Vol 24 (6) ◽  
pp. 515-522 ◽  
Author(s):  
Ellis H. B. Magnée ◽  
Gerdien H. de Weert-van Oene ◽  
Toon A. G. M. Wijdeveld ◽  
Anton M. L. Coenen ◽  
Cor A. J. de Jong
Keyword(s):  
Quality Of Life ◽  
Substance Use ◽  
Substance Use Disorders ◽  
Sleep Disturbances ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Determinants of Health-related Quality of Life in Recently Detoxified Patients With Severe Alcohol Use Disorder

2021 ◽  
Author(s):  
Najlaa Lahbairi ◽  
Alice Laniepce ◽  
Shailendra Segobin ◽  
Nicolas Cabé ◽  
Céline Boudehent ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Alcohol Use ◽  
Sleep Quality ◽  
Alcohol Use Disorder ◽  
Treatment Success ◽  
Health Related Quality ◽  
Quality Of Life Scale ◽  
Related Quality ◽  
Health Related

Abstract Background. Health-related quality of life (HRQoL) is an important clinical outcome in Alcohol Use Disorder (AUD) and is considered as a relevant indicator of treatment success. While a better understanding of the factors affecting HRQoL would enable to adjust patients’ care to favour treatment outcome, the determinants of HRQoL in AUD remain unclear. This study aims at describing HRQoL in AUD patients and at identifying its best predictors. Methods. We included 53 recently detoxified patients with severe AUD (sAUD) and 38 healthy controls (HC). They underwent a cognitive assessment and filled in questionnaires concerning socio-demographics, alcohol history, sleep quality, depression, anxiety and impulsivity. Additionally, a HRQoL questionnaire especially designed for AUD patients (Alcohol Quality of Life Scale; AQoLS) was used.Results. sAUD patients reported that alcohol affects their HRQoL mainly in the “negative emotions”, “control”, “relationships”, and “sleep” domains. Compared to HC, they were impaired on episodic memory, working memory, executive functions, and processing speed tasks. They also reported lower sleep quality, higher depression, anxiety and impulsivity. No association was found between AQoLS total score and socio-demographics, cognitive performance, or sleep quality in patients. We found a significant correlation between HRQoL and depression/anxiety as well as impulsivity. Anxiety and impulsivity were indeed the only significant predictors of HRQoL, explaining 47.7% of the variance. Conclusions. Anxiety and impulsivity are crucial determinants of HRQoL in recently detoxified sAUD patients. Since anxiety and impulsivity are frequent issues in addiction and especially in AUD, they should be particularly considered by clinicians to favour treatment outcomes.

scholarly journals Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life

PLoS ONE ◽  
2011 ◽  
Vol 6 (4) ◽  
pp. e18440 ◽  
Author(s):  
Jimena Fiz ◽  
Marta Durán ◽  
Dolors Capellà ◽  
Jordi Carbonell ◽  
Magí Farré
Keyword(s):  
Quality Of Life ◽  
Cannabis Use ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Alexithymia in Patients With Substance Use Disorders and Its Relationship With Psychiatric Comorbidities and Health-Related Quality of Life

2021 ◽  
Vol 12 ◽  
Author(s):  
Raul F. Palma-Álvarez ◽  
Elena Ros-Cucurull ◽  
Constanza Daigre ◽  
Marta Perea-Ortueta ◽  
Pedro Serrano-Pérez ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Substance Use ◽  
Psychiatric Disorders ◽  
Psychological Symptoms ◽  
Health Related Quality ◽  
Cross Sectional ◽  
Psychiatric Comorbidities ◽  
Related Quality ◽  
Health Related

Background: Alexithymia frequently correlates with several psychiatric disorders, including substance use disorder (SUD). However, most studies reporting the associations between alexithymia and psychiatric disorders have been performed in populations without SUD. This research, therefore, evaluates alexithymia in Spanish patients with SUD and the relationship among alexithymia, psychiatric comorbidities, psychological symptoms/traits, SUD variables, and health-related quality of life (HRQoL).Methodology: A cross-sectional study was conducted with 126 Spanish outpatients with SUD (75.4% males; mean age 43.72 ± 14.61 years), correlating their alexithymia levels (using the Toronto Alexithymia Scale 20 [TAS-20]) to their psychiatric comorbidities, psychological symptoms/traits, SUD variables, and HRQoL.Results: Alexithymia was significantly higher in patients who had cannabis use disorder. Higher alexithymia scores were also related to higher levels of depression, anxiety, impulsivity, and lower HRQoL. After multivariate analysis, trait anxiety, impulsivity, and the physical component summary of the HRQoL were found to be independently related to alexithymia.Conclusions: SUD patients with higher alexithymia levels have more frequently psychiatric comorbidities, present specific psychological features, and have worse HRQoL. Hence, it is important to evaluate these factors and offer more accurate psychotherapeutic approaches for this patient population.

scholarly journals Health-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up

2020 ◽  
Vol 9 (10) ◽  
pp. 3110
Author(s):  
Julia E. Marquez-Arrico ◽  
José Francisco Navarro ◽  
Ana Adan
Keyword(s):  
Quality Of Life ◽  
Substance Use ◽  
Major Depressive Disorder ◽  
Depressive Symptoms ◽  
Depressive Symptomatology ◽  
Health Related Quality ◽  
Major Depressive ◽  
Related Quality ◽  
Health Related

Health-related quality of life (HRQoL) assessment has interest as an indicator of degree of affectation and prognosis in mental disorders. HRQoL is impaired in both Substance Use Disorder (SUD) and Major Depressive Disorder (MDD), two conditions highly prevalent, although less studied when both are coexisting (SUD + MDD). Hence, we decided to explore HRQoL with the SF-36 survey in a sample of 123 SUD and 114 SUD + MDD patients (51 symptomatic and 63 asymptomatic of depressive symptoms) under treatment. We performed analyses to examine HRQoL among groups, and its predictive value at 3-, 6- and 12-month follow-ups through regression models. Patients with SUD + MDD had worse HRQoL than SUD patients and population norms. For Mental Health, Vitality, and General Health dimensions, lower scores were observed for SUD + MDD regardless the presence/absence of depressive symptoms. For Physical Functioning and Health Change, depressive symptomatology and not the comorbidity of SUD + MDD diagnoses explained HRQoL limitations. At 3-, 6- and 12-month follow-ups we observed two predictors of relapses, General Health for asymptomatic SUD + MDD, and Physical Functioning for SUD. Improving HRQoL in SUD + MDD may be targeted during patient’s treatment; future studies should explore the influence of HRQoL on patient’s prognosis taking into account the presence/absence of depressive symptomatology.

Sign in / Sign up

Export Citation Format

Share Document